Deal Dive: A cellular ag startup with a real moat


Share post:

Would you eat lab-grown meat? Would you give the same answer if someone asked you to use a beauty product that had lab-grown collagen as an ingredient?

Cellular agriculture — the process of growing an agriculture product from cell cultures — has been gaining momentum over the past few years. Earlier this year, the U.S. Food and Drug Administration approved Upside Foods’ and Good Meat’s plan to sell their lab-grown chicken through restaurants. Both companies, in addition to numerous other cellular agriculture startups, have raised oodles of venture dollars.

The rise of cellular agriculture hasn’t been linear and easygoing, of course, and not everyone is into the craze. Italy, for one, is working to ban the stuff outright, and various polls have produced mixed results regarding whether folks would actually eat lab-grown meat.

But not everyone is using the tech to create yet another meat alternative.

Stephanie Michelsen first realized the potential of cellular agriculture when she was working in the alternative protein sector. When she started thinking about it further, she realized there may be an overlooked opportunity: Animal proteins like gelatin and collagen have use cases well beyond the realm of food.

“I started thinking about the hurdles for moving into an animal-free future. If all animal culture disappeared tomorrow, what would be missing? What do we not have a solution for?” Michelsen said. “For me, it was the byproducts that are only found in these animals. That is how I landed on collagen.”

Cultivated collagen is the basis for her startup Jellatech, which was founded in 2020 and recently landed a $3.5 million seed round led by byFounders VC, with participation from Milano Investment Partners and Joyful VC, among others.

Jellatech stands out in the increasingly crowded cellular agriculture space because it is tapping into a larger opportunity than some of its seafood and meat-focused counterparts.

Source link

Lisa Holden
Lisa Holden
Lisa Holden is a news writer for LinkDaddy News. She writes health, sport, tech, and more. Some of her favorite topics include the latest trends in fitness and wellness, the best ways to use technology to improve your life, and the latest developments in medical research.

Recent posts

Related articles

How much can artists make from generative AI? Vendors won’t say

As tech companies begin to monetize generative AI, the creators on whose work it is trained are...

Venture capital is opening the gates for defense tech

Welcome to the TechCrunch Exchange, a weekly startups-and-markets newsletter. It’s inspired by the daily TechCrunch+ column where...

Humane’s ‘AI Pin’ debuts on the Paris runway

You’d better believe that Humane is going to milk the media hype cycle for all it’s worth....

Kick streamers consider leaving over CEO’s comments in a sex worker ‘prank’ stream

Streamers are leaving Kick en masse in protest of the platform’s lack of safety guidelines, after a...

VW bails on its plan for a $2.1B EV plant in Germany

Volkswagen’s $2.1 billion plan to launch a dedicated electric-vehicle factory in Wolfsburg, Germany is kaput.  The automaker instead...

When predatory investors damage your chances of success

Welcome to Startups Weekly. Sign up here to get it in your inbox every Friday. You know what...

Pudgy Penguins’ approach may be the answer to fixing NFTs’ revenue problems

Pudgy Penguins was once solely known for its 8,888 NFT collection. But ever since 24-year-old Luca Netz...

VC Office Hours: How data can help improve social impact investing

Erin Harkless Moore was always interested in math. So she headed to Wall Street. “It was intoxicating...